Genelex Corporation
Related Experiment Video
Updated: Jul 6, 2026

An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness
Published on: May 7, 2018
Howard Coleman1, Kristine Ashcraft
1Genelex Corporation, 3000 First Ave., Ste. One, Seattle, WA 98121, USA. hcoleman@genelex.com
Abstract:
Comprehensive, personalized medication management and pharmacogenetic testing are important existing opportunities to reduce adverse medication events and improve overall healthcare outcomes. A primary barrier to the adoption of personalized pharmacology is the inadequacy of existing patient records, drug interaction tools and the 'interpretation gap'--the lack of physician decision support tools needed to interpret DNA test reports. GeneMedRx, an algorithm-driven, gene-drug interaction software, closes this gap. It helps physicians optimize medication regimens by correlating the genetic makeup of the patient with all the medicines they are taking. Portable personal health records created by GeneMedRx are the core product required for a much-needed comprehensive program of personalized medication management.
Related Concept Videos
Transgenic Organisms
Transgenic Organisms
Gene Therapy
Gene Therapy
Pharmacogenomics: Identification of New Drug Targets
What is Genetic Engineering?

